blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1161227

EP1161227 - MICROPARTICLES FOR DELIVERY OF NUCLEIC ACID [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.03.2012
Database last updated on 17.09.2024
Most recent event   Tooltip04.05.2012Lapse of the patent in a contracting state
New state(s): IT		published on 06.06.2012  [2012/23]
Applicant(s)For all designated states
Eisai Inc.
100 Tice Boulevard
Woodcliff Lake, NJ 07677 / US
[2009/46]
Former [2009/20]For all designated states
Eisai Corporation of North America
100 Tice Boulevard
Woodcliff Lake, NJ 07677 / US
Former [2009/11]For all designated states
MGI PHARMA Biologics, Inc.
35 Hartwell Avenue
Lexington, MA 02421 / US
Former [2009/04]For all designated states
MGI PHARMA Biologics, Inc.
763 East Concord Avenue
Cambridge, MA 02138 / US
Former [2001/50]For all designated states
Zycos Inc.
763 East Concord Avenue
Cambridge, MA 02138 / US
Inventor(s)01 / LUNSFORD, Lynn, B.
151 North Road
Bedford, MA 01730 / US
02 / PUTNAM, David
143 Otis Street
Cambridge, MA 02141 / US
03 / HEDLEY, Mary, Lynne
51 Follen Road
Lexington, MA 02173 / US
 [2001/50]
Representative(s)Arends, William Gerrit, et al
Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[N/P]
Former [2006/18]Arends, William Gerrit, et al
Lloyd Wise Commonwealth House 1-19 New Oxford Street
London WC1A 1LW / GB
Former [2001/50]Bowman, Paul Alan, et al
LLOYD WISE, TREGEAR & CO., Commonwealth House, 1-19 New Oxford Street
London WC1A 1LW / GB
Application number, filing date00919403.610.03.2000
[2001/50]
WO2000US06578
Priority number, dateUS1999026646311.03.1999         Original published format: US 266463
US1999032134627.05.1999         Original published format: US 321346
[2001/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0053161
Date:14.09.2000
Language:EN
[2000/37]
Type: A2 Application without search report 
No.:EP1161227
Date:12.12.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.2000 takes the place of the publication of the European patent application.
[2001/50]
Type: B1 Patent specification 
No.:EP1161227
Date:11.05.2011
Language:EN
[2011/19]
Search report(s)International search report - published on:EP01.02.2001
ClassificationIPC:A61K9/16, A61K48/00, C12N15/88
[2001/50]
CPC:
C12N15/88 (EP); A61K39/0008 (EP); A61K39/12 (EP);
A61K39/205 (EP); A61K39/292 (EP); A61K9/1617 (EP);
A61K9/1647 (EP); A61P1/16 (EP); A61P19/02 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61K2039/53 (EP); A61K2039/55555 (EP); A61K2039/55566 (EP);
A61K2039/57 (EP); A61K2039/6093 (EP); C12N2710/20022 (EP);
C12N2710/20034 (EP); C12N2730/10134 (EP); C12N2760/20234 (EP);
Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/50]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:MIKROPARTIKEL ZUR VERABREICHUNG VON NUKLEINSÄUREN[2001/50]
English:MICROPARTICLES FOR DELIVERY OF NUCLEIC ACID[2001/50]
French:MICROPARTICULES POUR L'ADMINISTRATION DE L'ACIDE NUCLEIQUE[2001/50]
Entry into regional phase09.10.2001National basic fee paid 
09.10.2001Designation fee(s) paid 
09.10.2001Examination fee paid 
Examination procedure11.10.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.10.2001Amendment by applicant (claims and/or description)
09.10.2001Examination requested  [2001/50]
21.03.2005Despatch of a communication from the examining division (Time limit: M06)
19.01.2006Reply to a communication from the examining division
08.02.2006Despatch of a communication from the examining division (Time limit: M06)
18.08.2006Reply to a communication from the examining division
15.09.2006Despatch of a communication from the examining division (Time limit: M06)
26.03.2007Reply to a communication from the examining division
14.05.2007Despatch of a communication from the examining division (Time limit: M06)
07.01.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
14.03.2008Reply to a communication from the examining division
10.11.2009Date of oral proceedings
20.01.2010Minutes of oral proceedings despatched
15.03.2010Communication of intention to grant the patent
26.07.2010Fee for grant paid
26.07.2010Fee for publishing/printing paid
07.09.2010Despatch of a communication from the examining division (Time limit: M06)
14.03.2011Reply to a communication from the examining division
Opposition(s)14.02.2012No opposition filed within time limit [2012/16]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
14.03.2008Request for further processing filed
14.03.2008Full payment received (date of receipt of payment)
Request granted
01.04.2008Decision despatched
19.01.2006Request for further processing filed
19.01.2006Full payment received (date of receipt of payment)
Request granted
03.02.2006Decision despatched
Fees paidRenewal fee
22.03.2002Renewal fee patent year 03
24.03.2003Renewal fee patent year 04
22.03.2004Renewal fee patent year 05
22.03.2005Renewal fee patent year 06
29.03.2006Renewal fee patent year 07
28.03.2007Renewal fee patent year 08
27.03.2008Renewal fee patent year 09
26.03.2009Renewal fee patent year 10
25.03.2010Renewal fee patent year 11
28.03.2011Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT11.05.2011
BE11.05.2011
CY11.05.2011
DK11.05.2011
FI11.05.2011
IT11.05.2011
NL11.05.2011
SE11.05.2011
GR12.08.2011
ES22.08.2011
PT12.09.2011
[2012/23]
Former [2012/10]AT11.05.2011
BE11.05.2011
CY11.05.2011
DK11.05.2011
FI11.05.2011
NL11.05.2011
SE11.05.2011
GR12.08.2011
ES22.08.2011
PT12.09.2011
Former [2012/01]AT11.05.2011
BE11.05.2011
CY11.05.2011
FI11.05.2011
NL11.05.2011
SE11.05.2011
GR12.08.2011
ES22.08.2011
PT12.09.2011
Former [2011/49]CY11.05.2011
FI11.05.2011
SE11.05.2011
GR12.08.2011
ES22.08.2011
PT12.09.2011
Former [2011/47]PT12.09.2011
Cited inInternational search[A]FR2660556  (RHONE POULENC SANTE [FR]) [A] 1-75 * the whole document *;
 [A]EP0761211  (HOFFMANN LA ROCHE [CH]) [A] 1-75 * the whole document *;
 [X]WO9831398  (PANGAEA PHARMACEUTICALS INC [US], et al) [X] 1-10,14-45,48-56,60-75 * the whole document *;
 [X]WO9831346  (MASSACHUSETTS INST TECHNOLOGY [US], et al) [X] 1-4,7,34,35,37-44,46,47,49-51,53-55,57-69,71-75 * abstract * * page 5, line 28 - page 7, line 2 * * page 9, line 11 - page 15, line 20 * * page 20, line 1 - page 21, line 14 * * claims 1,5,6,11,12,14-16 *;
 [A]WO9851279  (MICROBIOLOGICAL RES AUTHORITY [GB], et al) [A] 1 * the whole document *;
 [PX]WO0003660  (SKYEPHARMA INC [US]) [PX] 1-6,34-42,44,46-50,53-55,57,58,63-68,71-75 * abstract * * page 1, line 1 - page 8, line 28 * * page 11, line 1 - page 18, line 16; claims 1,7-10,17 ** page 1 *;
 [A]  - GHADERI, RAOUF ET AL, "Effect of preparative parameters on the characteristics of poly (DL- lactide -co- glycolide ) microspheres made by the double emulsion method", INT. J. PHARM. (1996), 141(1,2), 205-216, XP000946093 [A] 1-75 * the whole document *

DOI:   http://dx.doi.org/10.1016/0378-5173(96)04639-X
 [A]  - ALONSO MARIA J ET AL, "Determinants of release rate of tetanus vaccine from polyester microspheres.", PHARMACEUTICAL RESEARCH (NEW YORK), (1993), vol. 10, no. 7, ISSN 0724-8741, pages 945 - 953, XP000946086 [A] 1-75 * the whole document *

DOI:   http://dx.doi.org/10.1023/A:1018942118148
by applicantUS5580959
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.